VISCHER advised LASCCO SA on all legal issues related to the license agreement. LASCCO SA, a biomedical-technology company, and Abionic SA, a nanotechnology company, both based...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised the investors while VISCHER acted as legal advisor to Nouscom in the transaction. Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized...
You must be a Standard 1 Year member to access this content.
VISCHER advised Memo Therapeutics on the financing. Memo Therapeutics AG, a late-stage biotech company developing best-in-class therapeutic antibodies closed a CHF25 million series C financing round...
You must be a Standard 1 Year member to access this content.
VISCHER advised Swiss Post on its acquisition of a stake in STERIPARC SA. Swiss Post acquired a stake in the company Steriparc SA, a joint venture for...
You must be a Standard 1 Year member to access this content.
VISCHER acted as legal advisor to LimmaTech Biologics in the transaction. LimmaTech Biologics AG closed a USD 37m (CHF 33m) Series A financing round co-led by Adjuvant...
You must be a Standard 1 Year member to access this content.
VISCHER acted as legal counsel to Afinum on this transaction. Afinum invests in Hofstetter PCB AG (Hofstetter), the leading European provider of printed circuit boards plating...
You must be a Standard 1 Year member to access this content.
VISCHER advises Epiterna with Prima Materia investment. Epiterna, a Swiss longevity company founded in 2022 by Alejandro Ocampo and Kevin Perez as a spin-off from Alejandro...
You must be a Standard 1 Year member to access this content.
VISCHER advised Relief regarding the Swiss legal aspects of this transaction. Relief Therapeutics Holding SA (SIX: RLF, OTCQB: RLFFD, RLFTD) has entered into a definitive agreement for the...
You must be a Standard 1 Year member to access this content.
VISCHER advised Battery Ventures in the transaction as Swiss counsel alongside White & Case. US private equity investor Battery Ventures acquired Swiss-based SaaS startup Avrios International...
You must be a Standard 1 Year member to access this content.
VISCHER advised the selling Herbonis shareholders in this transaction. Innovad, a leading provider of animal nutrition and health solutions, is pleased to announce that it is...
You must be a Standard 1 Year member to access this content.
VISCHER advised Rigeto on all legal aspects of the cross-border transaction. A group of investors advised by Munich-based Rigeto Unternehmerkapital GmbH has acquired prevention-center as an add-on...
You must be a Standard 1 Year member to access this content.
VISCHER advises Mosanna Therapeutics on the deal. Mosanna Therapeutics AG closes an extension of the Seed Financing Round with the investors Supermoon Capital and High-Tech Gründerfonds...
You must be a Standard 1 Year member to access this content.
